Valencia Nutrition [VALENCIA] vs Biocon [BIOCON] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Valencia Nutrition Ltd. wins in 7 metrics, Biocon Ltd. wins in 11 metrics, with 0 ties. Biocon Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Valencia Nutrition Ltd. Biocon Ltd. Better
P/E Ratio (TTM) 38.74 71.84 Valencia Nutrition Ltd.
Price-to-Book Ratio 3.56 1.68 Biocon Ltd.
Debt-to-Equity Ratio 47.66 50.02 Valencia Nutrition Ltd.
PEG Ratio N/A 0.17 N/A
EV/EBITDA 47.50 19.22 Biocon Ltd.
Profit Margin (TTM) 27.73% 3.59% Valencia Nutrition Ltd.
Operating Margin (TTM) 19.80% 7.63% Valencia Nutrition Ltd.
EBITDA Margin (TTM) 19.80% 7.63% Valencia Nutrition Ltd.
Return on Equity 10.80% 3.66% Valencia Nutrition Ltd.
Return on Assets (TTM) 4.41% 1.72% Valencia Nutrition Ltd.
Free Cash Flow (TTM) $-198.09M $17.18B Biocon Ltd.
Dividend Yield N/A 0.26% N/A
1-Year Return 25.56% 27.63% Biocon Ltd.
Price-to-Sales Ratio (TTM) 12.67 3.37 Biocon Ltd.
Enterprise Value $1.50B $643.51B Biocon Ltd.
EV/Revenue Ratio 14.13 3.82 Biocon Ltd.
Gross Profit Margin (TTM) -453.63% 67.91% Biocon Ltd.
Revenue per Share (TTM) $6 $133 Biocon Ltd.
Earnings per Share (Diluted) $2.02 $4.87 Biocon Ltd.
Beta (Stock Volatility) 0.51 0.25 Biocon Ltd.

Valencia Nutrition Ltd. vs Biocon Ltd. Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Valencia Nutrition Ltd.-7.01%-12.11%-2.27%1.52%-10.87%-9.78%
Biocon Ltd.-1.04%-4.57%14.38%9.01%0.60%6.37%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Valencia Nutrition Ltd.25.56%46.69%302.48%225.81%225.81%225.81%
Biocon Ltd.27.63%78.42%11.37%265.74%609.92%1,204.47%

Performance & Financial Health Analysis: Valencia Nutrition Ltd. vs Biocon Ltd.

MetricVALENCIABIOCON
Market Information
Market Cap i₹1.09B₹566.52B
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i3,7502,496,867
90 Day Avg. Volume i4,2003,790,310
Last Close₹63.28₹412.45
52 Week Range₹47.00 - ₹97.10₹327.60 - ₹440.40
% from 52W High-34.83%-6.35%
All-Time High₹97.10 (Nov 07, 2025)₹487.75 (Dec 21, 2020)
% from All-Time High-34.83%-15.44%
Growth Metrics
Quarterly Revenue Growth1.39%0.09%
Quarterly Earnings GrowthN/A4.73%
Financial Health
Profit Margin (TTM) i0.28%0.04%
Operating Margin (TTM) i0.20%0.08%
Return on Equity (TTM) i0.11%0.04%
Debt to Equity (MRQ) i47.6650.02
Cash & Liquidity
Book Value per Share (MRQ)₹21.98₹207.92
Cash per Share (MRQ)₹0.16₹45.84
Operating Cash Flow (TTM) i₹-148,430,000₹17.78B
Levered Free Cash Flow (TTM) i₹-326,869,504₹10.13B
Dividends
Last 12-Month Dividend Yield iN/A0.26%
Last 12-Month Dividend iN/A₹1.00

Valuation & Enterprise Metrics Analysis: Valencia Nutrition Ltd. vs Biocon Ltd.

MetricVALENCIA (Apr 24, 2026)BIOCON (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i38.7471.84
Forward P/E iN/A38.56
PEG Ratio iN/A0.17
Price to Sales (TTM) i12.673.37
Price to Book (MRQ) i3.561.68
Market Capitalization
Market Capitalization i₹1.09B₹566.52B
Enterprise Value i₹1.50B₹643.51B
Enterprise Value Metrics
Enterprise to Revenue i14.133.82
Enterprise to EBITDA i47.5019.22
Risk & Other Metrics
Beta i0.510.25
Book Value per Share (MRQ) i₹21.98₹207.92

Financial Statements Comparison: Valencia Nutrition Ltd. vs Biocon Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricVALENCIA (2025)BIOCON (2025)
Revenue/Sales i84.71M150.52B
Cost of Goods Sold i44.84M51.98B
COGS % of Revenue i52.9%34.5%
Gross Profit i39.87M98.54B
Gross Margin i47.1%65.5%
Research & Development iN/A6.34B
Operating Income (EBIT) i6.46M16.26B
Operating Margin i7.6%10.8%
EBITDA i13.36M33.60B
EBITDA Margin i15.8%22.3%
Pre-Tax Income i10.74M18.87B
Pre-Tax Income % of Revenue i12.7%12.5%
Income Tax i04.57B
Income Tax % of Revenue i0.0%3.0%
Net Income (Profit) i10.74M14.29B
Profit Margin i12.7%9.5%

Balance Sheet & Liquidity Metrics

MetricVALENCIA (2025)BIOCON (2025)
Cash & Equivalents i1.41M32.27B
Total Current Assets i272.88M162.86B
Total Current Assets % of Revenue i322.1%108.2%
Total Current Liabilities i3.49M143.34B
Total Current Liabilities % of Revenue i4.1%95.2%
Long-Term Debt i14.87M129.45B
Long-Term Debt % of Revenue i17.6%86.0%
Total Shareholders Equity i365.81M277.13B
Retained Earnings i-179.82M189.59B
Retained Earnings % of Revenue i-212.3%126.0%
Property, Plant & Equipment i3.27M4.32B

Cash Flow Statement Comparison

MetricVALENCIA (2025)BIOCON (2025)
Operating Cash Flow i-158.47M17.78B
Operating Cash Flow % of Revenue i-187.1%11.8%
Capital Expenditures i-40.80M-21.36B
Free Cash Flow i-198.09M17.18B
FCF Margin i-233.8%11.4%
Debt Repayment i-38.53M-97.70B
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricVALENCIABIOCON
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i16.98M1.62B
Float Shares i2.49M583.07M
% Held by Insiders i81.67%54.07%
% Held by Institutions i0.00%24.88%
% Held by Public i18.33%21.05%

Dividend Analysis & Yield Comparison: Valencia Nutrition Ltd. vs Biocon Ltd.

MetricVALENCIABIOCON
Last 12-Month Dividend iN/A₹1.00
Last 12-Month Dividend Yield iN/A0.26%
3-Year Avg Annual Dividend iN/A₹1.33
3-Year Avg Dividend Yield iN/A0.36%
3-Year Total Dividends iN/A₹4.00
Ex-Dividend DateN/AJul 04, 2025